Developmental Cancer Therapeutics Members
Translational Research - Neural Stem Cell as Delivery tool for Cancer Treatment.
Andrea Bild, Ph.D. is a professor in the Division of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research at City of Hope
Shiuan Chen, Ph.D., chairs the Department of Cancer Biology and Molecular Medicine at the Beckman Research Institute of City of Hope.
Vincent Chung, M.D., is a medical oncologist specializing in pancreatic cancer and gastrointestinal cancers.
Marwan G. Fakih, M.D., is a medical oncologist specializing in gastrointestinal cancers.
Ajay Goel, Ph.D., AGAF, associate director of basic science, comprehensive cancer center; professor and chair, Department of Molecular Diagnostics and Experimental Therapeutics, researches molecular pathogenesis of human gastrointestinal cancers and its relationship to early detection of cancer
Regenerative medicine for Traumatic Brain Injury.
Stanley Hamilton, M.D., is a professor in the Department of Pathology.
Robert Hickey, Ph.D., is an Associate Professor in the Department of Cancer Biology and Molecular Medicine at the Beckman Research Institute of City of Hope.
City of Hope's neurosurgeon and scientist, Rahul Jandial, M.D., Ph.D., specializes in brain, spine and spinal cord cancers.
Tijana Jovanovic-Talisman, Ph.D., is an Associate Professor in the Department of Cancer Biology and Molecular Medicine at Beckman Research Institute of City of Hope
Lily Lai, M.D., is a surgical oncologist and professor in the Division of Colorectal Surgery, Department of Surgery.
Clayton Lau, M.D., is the Director of the Prostate Cancer Program for City of Hope's Comprehensive Cancer Center in the Los Angeles region. He is also the Pauline & Martin Collins Family Chair in Urology and a top-ranked urologic surgeon.
Linda Malkas, Ph.D., is a professor in the Department of Molecular Diagnostics & Experimental Therapeutics at Beckman Research Institute of City of Hope.
Sumanta Kumar Pal, M.D., FASCO, is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Jana Portnow, M.D., is a medical oncologist and co-director of the Brain Tumor Program at City of Hope. She is dedicated to improving the treatment of the most aggressive and difficult brain cancers.
Dr. Rockne serves as director of the Division of Mathematical Oncology and Computational Systems Biology, with the goal of translating mathematics, physics and evolution-based research to clinical care.
Andrei S. Rodin, Ph.D., research interests are (i) computational systems biology — both methodology development and application to diverse high-dimensional multiscale biomedical data, and (ii) molecular evolution.
Lorna Rodriguez-Rodriguez, M.D., Ph.D., is eagerly continuing her ovarian cancer investigations at City of Hope, which she calls “the perfect environment” that's home to “many amazing scientists and clinicians (with) similar goals about making discoveries to cure cancer.”
Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope and an expert in the study and treatment of lung cancer, mesothelioma, thoracic and thymic malignancies and bronchial carcinoids.
Sharad Singhal, Ph.D., is a professor of medical oncology & therapeutics research at Beckman Research Institute of City of Hope, and an affiliate full member of City of Hope's comprehensive cancer center and the Developmental Cancer Program and Therapeutics at City of Hope, Duarte, California.
Timothy Synold, Pharm,D., is director of the Analytical Pharmacology Core, and a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope.
Nagarajan Vaidehi, Ph.D., is a scientist, educator and leader with a career-long commitment to developing computational methods to simulate dynamics of proteins involved in signal transduction pathways and using them for the discovery of next generation drugs with lower side effects. Dr. Vaidehi is
Daneng Li, M.D., is a medical oncologist specializing in geriatric oncology and treating gastrointestinal cancers.
In her capacity as director of thoracic medical oncology at the City of Hope Orange County, Jyoti Malhotra, M.D., M.P.H., is excited about offering patients an expansive slate of early-phase clinical trials in order to offer more people access to new therapies.
Edward Wenge Wang, M.D., Ph.D., is the section chief of the Gynecologic Oncology and assistant professor in the Department of Medical Oncology & Therapeutics Research.
Terence M. Williams, M.D., Ph.D., is professor and chair of the Department of Radiation Oncology, City of Hope in Duarte, Southern California.
Yan Xing, M.D., Ph.D., is a medical oncologist and an assistant professor in the Department of Medical Oncology & Therapeutics Research.
John Yim, M.D., is a breast cancer, thyroid cancer and endocrine disorders surgeon.
TGEN MEMBERS
Professor and Director, Cancer and Cell Biology Division
Head, Basic Research Unit, Pancreatic Cancer Program
Professor, Molecular Medicine Division
Sunil Sharma, M.D., M.B.A.
Deputy Director, Clinical Sciences
Professor and Director, Applied Cancer Research and Drug Discover Division at TGen
Chief, Translational Oncology Research and Drug Discovery at HonorHealth Research Institute
Co-Leader, Developmental Cancer Therapeutics Program
Physician-in-Chief, TGen
Distinguished Professor and Director, Molecular Medicine Division